Edwards Intuity surgical aortic valve nets CE Mark

Edwards Lifesciences, a developer of heart valves and hemodynamic monitoring systems, has received CE Mark in Europe for its Edwards Intuity valve system for use in patients undergoing surgical aortic valve replacement (AVR).

The system, which consists of a bovine pericardial heart valve and delivery system, facilitates small incision surgery and valve deployment during AVR procedures. The company plans to begin a European launch at centers participating in post-approval clinical studies. Edwards Intuity leverages the design of Edwards' pericardial valve technology, featuring a balloon-expandable frame designed to facilitate annular placement.

The Edwards Intuity valve system is not yet available for sale or use in the U.S.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.